Home302440 • KRX
add
SK Bioscience Co Ltd
Nakaraang pagsara
₩44,150.00
Sakop ng araw
₩43,950.00 - ₩44,450.00
Sakop ng taon
₩38,700.00 - ₩61,300.00
Market cap
3.48T KRW
Average na Volume
111.33K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (KRW) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 184.19B | 17.43% |
Gastos sa pagpapatakbo | 56.40B | 1.11% |
Net na kita | -57.96B | -800.43% |
Net profit margin | -31.47 | -667.56% |
Kita sa bawat share | -740.00 | -825.00% |
EBITDA | -25.91B | 11.16% |
Aktuwal na % ng binabayarang buwis | -164.62% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (KRW) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 906.30B | -21.74% |
Kabuuang asset | 2.96T | 3.94% |
Kabuuang sagutin | 918.29B | 11.83% |
Kabuuang equity | 2.04T | — |
Natitirang share | 78.43M | — |
Presyo para makapag-book | 1.94 | — |
Return on assets | -4.39% | — |
Return on capital | -5.17% | — |
Cash Flow
Net change in cash
| (KRW) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -57.96B | -800.43% |
Cash mula sa mga operasyon | 23.66B | 282.78% |
Cash mula sa pag-invest | -128.66B | 51.96% |
Cash mula sa financing | 46.91B | -35.04% |
Net change in cash | -53.97B | 72.96% |
Malayang cash flow | -34.62B | 74.22% |
Tungkol
SK Bioscience is a South Korean biotechnology company that produces vaccines and other products and is a subsidiary of SK Chemicals. Wikipedia
CEO
Itinatag
Hul 1, 2018
Website
Mga Empleyado
1,067
